202 related articles for article (PubMed ID: 23971691)
1. Therapeutic approach for neuronal disease by regulating renin-angiotensin system.
Ohshima K; Mogi M; Horiuchi M
Curr Hypertens Rev; 2013 May; 9(2):99-107. PubMed ID: 23971691
[TBL] [Abstract][Full Text] [Related]
2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
3. Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues.
Borghi C; ; Rossi F;
High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):429-44. PubMed ID: 26403596
[TBL] [Abstract][Full Text] [Related]
4. Renin inhibition--benefit beyond hypertension control.
Kher V
J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
[TBL] [Abstract][Full Text] [Related]
5. Recent changes in the landscape of combination RAS blockade.
Epstein BJ; Smith SM; Choksi R
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
[TBL] [Abstract][Full Text] [Related]
6. Losartan, an Angiotensin type I receptor, restores erectile function by downregulation of cavernous renin-angiotensin system in streptozocin-induced diabetic rats.
Yang R; Yang B; Wen Y; Fang F; Cui S; Lin G; Sun Z; Wang R; Dai Y
J Sex Med; 2009 Mar; 6(3):696-707. PubMed ID: 19175863
[TBL] [Abstract][Full Text] [Related]
7. The renin-angiotensin system and diabetic nephropathy.
Gurley SB; Coffman TM
Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
[TBL] [Abstract][Full Text] [Related]
8. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review.
Almeida-Santos AF; Kangussu LM; Campagnole-Santos MJ
Protein Pept Lett; 2017 Nov; 24(9):841-853. PubMed ID: 28828974
[TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin system as a potential therapeutic target in stroke and retinopathy: experimental and clinical evidence.
Fouda AY; Artham S; El-Remessy AB; Fagan SC
Clin Sci (Lond); 2016 Feb; 130(4):221-38. PubMed ID: 26769658
[TBL] [Abstract][Full Text] [Related]
10. Anti-diabetic effect of blockade of the renin-angiotensin system.
Ando K; Fujita T
Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746
[TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy.
Giles TD
Rev Cardiovasc Med; 2007; 8 Suppl 2():S14-21. PubMed ID: 17401312
[TBL] [Abstract][Full Text] [Related]
12. Renin inhibition: a new modality for hypertension management.
Siragy HM
Curr Hypertens Rep; 2007 Aug; 9(4):291-4. PubMed ID: 17686379
[TBL] [Abstract][Full Text] [Related]
13. The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets.
Steckelings UM; Rompe F; Kaschina E; Unger T
Fundam Clin Pharmacol; 2009 Dec; 23(6):693-703. PubMed ID: 19817870
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic role of Renin-Angiotensin System blockers in obesity- related renal disorders.
Santos SH; Simões e Silva AC
Curr Clin Pharmacol; 2014 Feb; 9(1):2-9. PubMed ID: 23270435
[TBL] [Abstract][Full Text] [Related]
15. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.
Vaněčková I; Kujal P; Husková Z; Vaňourková Z; Vernerová Z; Certíková Chábová V; Skaroupková P; Kramer HJ; Tesař V; Červenka L
Kidney Blood Press Res; 2012; 35(5):382-92. PubMed ID: 22487948
[TBL] [Abstract][Full Text] [Related]
16. Dual blockade of the renin-angiotensin system in the progression of renal disease: the need for more clinical trials.
Fernandez-Juárez G; Barrio V; de Vinuesa SG; Goicoechea M; Praga M; Luño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S250-4. PubMed ID: 17130270
[TBL] [Abstract][Full Text] [Related]
17. Angiotensins in Alzheimer's disease - friend or foe?
Kehoe PG; Miners S; Love S
Trends Neurosci; 2009 Dec; 32(12):619-28. PubMed ID: 19796831
[TBL] [Abstract][Full Text] [Related]
18. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes.
Jandeleit-Dahm KA; Tikellis C; Reid CM; Johnston CI; Cooper ME
J Hypertens; 2005 Mar; 23(3):463-73. PubMed ID: 15716683
[TBL] [Abstract][Full Text] [Related]
19. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
Gerc V; Buksa M; Loza V; Kulic M
Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117
[TBL] [Abstract][Full Text] [Related]
20. Development of inhibitors of the aspartyl protease renin for the treatment of hypertension.
Scott BB; McGeehan GM; Harrison RK
Curr Protein Pept Sci; 2006 Jun; 7(3):241-54. PubMed ID: 16787263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]